Target intelligence / Profile preview

Novel transcript, antisense to ZNF641 (AC090115.1)

Target
AC090115.1
Molecular classification
Other (Antisense non-coding RNA)
01

Overview

ENSG00000257735 is a human non-coding RNA transcript, also known as AC090115.1, identified as an antisense RNA overlapping the ZNF641 gene. "Antisense" indicates that its RNA sequence is complementary to the messenger RNA (mRNA) of ZNF641 and may be involved in the regulation of that gene's expression through mechanisms such as RNA interference or transcriptional interference, though no specific function or therapeutic relevance has been described for this transcript in the literature to date. It is not a protein-coding gene, nor is it currently recognized as a receptor, enzyme, transporter, or any classical therapeutic target. There is no evidence supporting a role in disease, as a drug target, or as a biomarker[1][7]. Clarifications and limitations: - This entity is *not* a classical therapeutic target (such as a receptor, transporter, enzyme, or transcription factor). - It is a locus for a non-coding (antisense) RNA, with no known biological, pathological, or pharmacological role[1][7]. - Its entry as a “target” is likely incorrect or a mislabeling, as there is no evidence that it serves as a molecular target for drugs or as a marker in any disease setting. - No structured data on function, role, clinical relevance, or drug interaction is available for this locus. Summary: ENSG00000257735 (novel transcript, antisense to ZNF641/AC090115.1) is a non-coding RNA, without a known biological function, disease association, or drug interaction, and should *not* be considered a therapeutic target[1][7].

Other names
AC090115.1ENSG00000257735
02

Biological functions

Other (Potential regulatory antisense RNA; specific function uncharacterized)
03

Disease associations

Other (No evidence for direct disease association)

Beyond the preview

Go deeper on Novel transcript, antisense to ZNF641 (AC090115.1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to ZNF641 (AC090115.1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call